Recently, we determined expression of seven different phosphorylated residues on ERα in breast cancer samples from patients who subsequently were treated with tamoxifen, and found that multiple tumors expressed combinations of phospho-ERα epitopes [6]. This evidence concerns the gene ESR1 and breast cancer.